Genetic databases and pharmacogenetics: introduction

被引:2
|
作者
Ashcroft, Richard E. [1 ]
Hedgecoe, Adam M. [2 ]
机构
[1] Queen Mary Univ London, Inst Hlth Sci Educ, Abernethy Bldg,2 Newark St, London E1 2AT, England
[2] Univ Sussex, Sch Social Sci, Dept Sociol, Brighton BN1 9QN, E Sussex, England
关键词
Genetic databases; Pharmacogenetics; Industrial research; Bioethics;
D O I
10.1016/j.shpsc.2006.06.008
中图分类号
N09 [自然科学史]; B [哲学、宗教];
学科分类号
01 ; 0101 ; 010108 ; 060207 ; 060305 ; 0712 ;
摘要
Since the inception of the Human Genome Project, human genetics has frequently been conducted through big science projects, combining academic, state and industrial methods, interests and resources. The legitimacy of such projects has been linked to national prestige and images of the nation, the purity of scientific endeavour, the entrepreneurial spirit, medical progress and the public health. A key complication in these discourses is that large-scale genetic research has yet to show major results when considered in terms of the objectives used to legitimate investment and social support for these projects. The main area showing promise at present is the developing field of pharmacogenetics, which is now attracting major industry and government investment. Sociological, ethical and philosophical study of human genetic sample-based research and pharmacogenetics has developed in parallel with inquiry in the biological and biomedical sciences. This paper introduces a symposium on the ethical and social aspects of this field of biomedical research. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:499 / 502
页数:4
相关论文
共 50 条
  • [1] Genetic Databases and Their Pitfalls: An Example Related to Pharmacogenetics
    Pouche, L.
    Avcu, K.
    Esperon, P.
    Noceti, O.
    Marquet, P.
    Picard, N.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 713 - 714
  • [2] Databases in the Area of Pharmacogenetics
    Sim, Sarah C.
    Altman, Russ B.
    Ingelman-Sundberg, Magnus
    HUMAN MUTATION, 2011, 32 (05) : 526 - 531
  • [3] Genetic databases in pharmacogenetics: an example of common pitfall for less studied genes
    Pouche, L.
    Avcu, K.
    Esperon, P.
    Noceti, O.
    Marquet, P.
    Picard, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 74 - 74
  • [4] Editorial introduction: Symposium on Icelandic and UK Genetic Databases
    Glasner, P
    Rothman, H
    NEW GENETICS AND SOCIETY, 2001, 20 (02) : 101 - 102
  • [5] HUMAN PHARMACOGENETICS - INTRODUCTION
    WEINSHILBOUM, RM
    FEDERATION PROCEEDINGS, 1984, 43 (08) : 2295 - 2297
  • [6] Pharmacogenetics Working Party: introduction
    Stephen T. Holgate
    Martin W. Lunnon
    International Journal of Pharmaceutical Medicine, 2001, 15 (2) : 63 - 65
  • [7] Pharmacogenetics and Heart disease - Introduction
    Talmud, PJ
    VASCULAR PHARMACOLOGY, 2006, 44 (02) : 65 - 65
  • [8] DATABASES - INTRODUCTION
    KRAJEWSKI, R
    BYTE, 1984, 9 (11): : 135 - 135
  • [9] NEW DIRECTIONS IN PHARMACOGENETICS - INTRODUCTION
    VESELL, ES
    FEDERATION PROCEEDINGS, 1984, 43 (08) : 2319 - 2325
  • [10] Pharmacogenetics: Introduction and evolutionary aspects
    Ingelman-Sundberg, M
    DRUG METABOLISM REVIEWS, 2003, 35 : 19 - 19